Skip to content

A New Paradigm in eClinical Technology

1-888-488-0312 or

Menu

Home
eClinical Software
Services
Experience
Partners
- Contract Research Organizations
Contact Us
- Careers
- Newsletter Registration
News / Blog
On Air!

Menu

×

Home
eClinical Software
Services
Experience
Partners
- Contract Research Organizations
Contact Us
- Careers
- Newsletter Registration
News / Blog
On Air!

TrialStat Corporate Overview 23-09-2019

By Chris Kata | September 24, 2019

Latest News

Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer January 27, 2023
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy January 27, 2023
Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD) January 27, 2023
Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time January 26, 2023
Bio4t2 announces first patient infused with CAR-T targeting solid tumors January 26, 2023

Archives

Categories

TrialStat Solutions Inc.

Head Office:

16751, TransCanada Hwy
Kirkland (Montreal), QC
Canada H9H 4J4

Telephone: 1-888-488-0312
Technical Support: 1-866-416-7828 ext. 2
Fax: 1-613-274-3674

Reach Us By Email

Support: [email protected]
Sales: [email protected]

Meet Us Virtually

We are hosting a series of webinars over the coming months and would love to have you attend.

Upcoming Meetings

Additional Information

Privacy Policy
Press Releases

© 2023 TrialStat Solutions Inc. All Rights Reserved.